SALT POINT STRATEGIES

Lobbying for VERTEX PHARMACEUTICALS · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Non-opioid pain relief and drug pipeline issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem